Fracture risk is increased in patients with atrial fibrillation or receiving amiodarone

Fracture risk is increased in patients with atrial fibrillation or receiving amiodarone

Play all audios:

Loading...

Access through your institution Buy or subscribe Rejnmark L _ et al_. (2007) Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case–control study. _Osteoporosis Int_ 18: 409–417 Cardiac arrhythmias (atrial fibrillation being the most common) are mainly seen in the elderly, in whom osteoporotic fractures are also common. Whether associations exist between cardiac arrhythmias and the risk of fractures—caused by the heart disease itself or by adverse effects of antiarrhythmic drugs—is unclear. Rejnmark and colleagues conducted a population-based case–control study to investigate whether any such relationships can be identified. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Fracture risk is increased in patients with atrial fibrillation or receiving amiodarone. _Nat Rev Endocrinol_ 3, 504 (2007). https://doi.org/10.1038/ncpendmet0526 Download citation * Issue Date: July 2007 * DOI: https://doi.org/10.1038/ncpendmet0526 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative

Access through your institution Buy or subscribe Rejnmark L _ et al_. (2007) Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case–control


study. _Osteoporosis Int_ 18: 409–417 Cardiac arrhythmias (atrial fibrillation being the most common) are mainly seen in the elderly, in whom osteoporotic fractures are also common. Whether


associations exist between cardiac arrhythmias and the risk of fractures—caused by the heart disease itself or by adverse effects of antiarrhythmic drugs—is unclear. Rejnmark and colleagues


conducted a population-based case–control study to investigate whether any such relationships can be identified. This is a preview of subscription content, access via your institution ACCESS


OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on


SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about


institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Fracture risk is increased in


patients with atrial fibrillation or receiving amiodarone. _Nat Rev Endocrinol_ 3, 504 (2007). https://doi.org/10.1038/ncpendmet0526 Download citation * Issue Date: July 2007 * DOI:


https://doi.org/10.1038/ncpendmet0526 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative